Nov 19 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat patients with a so-called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback